By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sagent Pharmaceuticals, Inc. 

1901 N. Roselle Road
Suite 700
Schaumburg  Illinois  60195-3176  U.S.A.
Phone: 866-625-1618 Fax: n/a



Company News
Nichi-Iko Announces Results Of Tender Offer To Purchase All Of The Outstanding Shares Of Common Stock Of Sagent Pharma 8/29/2016 11:28:44 AM
Sagent Pharma Initiates A Nationwide Voluntary Recall Of Oxacillin For Injection, USP, 10 G Due To Presence Of Iron Oxide Particulate Matter 8/18/2016 8:11:42 AM
Nichi-Iko Announces Expiration Of HSR Waiting Period For Proposed Acquisition Of Sagent Pharma 8/9/2016 12:52:40 PM
Shepard Vision, A Wholly-Owned Subsidiary Of Nichi-Iko Commences All-Cash Tender Offer Of $21.75 Net Per Share To Acquire All Outstanding Shares Of Sagent Pharma 8/1/2016 11:30:41 AM
Sagent Pharma Announces The Launch Of Amikacin Sulfate Injection, USP 7/18/2016 8:25:12 AM
Japan's Nichi-Iko Takes Out Sagent Pharma for $736 Million Cash 7/11/2016 6:20:27 AM
Sagent Pharma Forks Over $40 Million for Five ANDAs from Teva (TEVA) 6/16/2016 6:48:08 AM
Sagent Pharma To Sell China Subsidiary At $50 Million Loss 1/5/2016 9:53:06 AM
Sagent Pharma Announces The Launch Of Chlorothiazide Sodium For Injection, USP 10/27/2015 2:28:33 PM
Sagent Pharma Reports Second Quarter 2015 Financial Results 8/4/2015 7:58:24 AM